Evidence map›Paper›PMID 24427744›Full record

ReviewFrontiers in cellular and infection microbiology2014

Pandemic Vibrio parahaemolyticus O3:K6 on the American continent.

Jorge Velazquez-Roman, Nidia León-Sicairos, Lucio de Jesus Hernández-Díaz, Adrian Canizalez-Roman

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
8.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Article
  3. Toxins · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Predator-Prey Interactions betweenMicrobiology spectrum · 2023
    Article
  12. Microbial genomics · 2023
    Article
  13. Article
  14. International journal of environmental research and public health · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jorge Velazquez-RomanSchool of Medicine, Autonomous University of Sinaloa Culiacan, Mexico.
Nidia León-SicairosSchool of Medicine, Autonomous University of Sinaloa Culiacan, Mexico ; Pediatric Hospital of Sinaloa Culiacan, Mexico.
Lucio de Jesus Hernández-DíazPrograma Regional Para el Doctorado en Biotecnología, FCQB-UAS Culiacan, México.
Adrian Canizalez-RomanSchool of Medicine, Autonomous University of Sinaloa Culiacan, Mexico ; The Sinaloa State Public Health Laboratory, Secretariat of Health Culiacan, Mexico.
Autonomous University of Sinaloa · MXPediatric Hospital of Sinaloa · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vibrio parahaemolyticus is one of the most important seafood-borne bacterial in recent years and is the leading causal agent of human acute gastroenteritis, primarily following the consumption of raw, undercooked or mishandled marine products. Until 1996, infections caused by V. parahaemolyticus were generally associated with diverse serovars. However, in February 1996, a unique serovar (O3:K6) of V. parahaemolyticus with specific genetic markers (tdh, toxRS/New and/or orf8) appeared abruptly in Kolkata, India. In subsequent years, O3:K6 isolates similar to those isolated in Kolkata have been reported from food borne outbreaks in Southeast Asia, as well as in the Atlantic and Gulf coasts of the United States (U.S). More recently, there have been reports in Europe, Africa and Central and South America. Specifically, in the American continent, some countries have reported cases of gastroenteritis due to the pandemic O3:K6 strain and its serovariants; the pandemic strain was first detected in Peru (1996, >100 cases), subsequently spreading to Chile in 1998 (>16,804 human cases), to the U.S. in 1998 (>700 cases), to Brazil in 2001 (>18 cases) and to Mexico in 2004 (>1200 cases). The arrival of the pandemic clone on the American continent may have resulted in a significant shift on the epidemic dynamics of V. parahaemolyticus. However, although O3:K6 is the predominant serovar of the recognized clinical strains in some countries in the Americas, a decrease in clinical cases caused by O3:K6 and an increase in cases associated with a new serotype (O3:K59, Chile) have been recently reported. The emergence and worldwide dissemination of O3:K6 and other pandemic strains since 1996 have come to represent a threat to public health and should concern health authorities. This review focuses on the presence, distribution and virulence factors of the V. parahaemolyticus O3:K6 pandemic clone and its serovariants in clinical and environmental strains on the American continent.

Indexed as

PandemicsAmericasFoodborne DiseasesGastroenteritisHumansSerotypingVibrio InfectionsVibrio parahaemolyticusAmerican continentbiosurveillancepandemic clonepublic healthserotypesVibrio parahaemolyticus

Identifiers

PMID24427744
PMCPMC3878053
OpenAlexW2080778982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.